Publications
To request a copy of any of the listed publications, please contact BioMS or visit PubMed to search for scientific literature.
2008: Therapy
Dirucotide (MBP8298) for the treatment of multiple sclerosis.
C. Markowitz
2006: European Journal of Neurology
Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment
K. G. Warren , I. Catz , L. Z. Ferenczi , M. J. Krantz
2000: Multiple Sclerosis (2000) Macmillan Publishers Ltd.
Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP85VVHFFKNIVTP96RT in multiple sclerosis patients
KG Warren and Ingrid Catz, University of Alberta
1997: Journal of the Neurological Sciences
Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85VVHFFKNIVTP96 in chronic progressive MS
KG Warren and Ingrid Catz, Kai Wucherpfennig
September 1997: The American Society for Clinical Investigations Inc.
Recognition of the Immunodominant Myelin Basic Protein Peptide by Autoantibodies and HLA-DR2 restricted T Cell Clones from Multiple Sclerosis Patients (identity of Key Contact Residues in the B-cell and T-cell Epitopes)
Kai W. Wucherpfennig, Ingrid Catz, Stephan Hausmann, Jack L. Strominger, Lawrence Steinman & Kenneth G. Warren
October 1996: Journal of the Neurological Sciences
The effect of intrathecal MBP synthetic peptides containing epotope P8 VHFFKNIVTP96 on free anti-MBP levels in acute relapsing multiple sclerosis
KG Warren and Ingrid Catz, University of Alberta
May 1995: Journal of the Neurological Sciences
Administration of myelin basic protein synthetic peptides to multiple sclerosis patients MBP75-95
KG Warren and Ingrid Catz, University of Alberta
1995: Proc. Natl, Acad. Sci USA
Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: The minimal B-cell epitope and a model of its features
K.G. Warren, Ingrid Catz and Lawrence Steinman
1994: Annals of Neurology
Anti-Myelin Basic Protein and Anti-Proteolipid Protein Specific Forms of Multiple Sclerosis
Kenneth G. Warren, Ingrid Catz, Edward Johnson and Bruce Mielke
1993: Journal of the Neurological Sciences
Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid
KG Warren and Ingrid Catz, University of Alberta
September 1992: Journal of Neuroimmunology
Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis
KG Warren and Ingrid Catz, University of Alberta
February 1992: Journal of Neuroimmunology
Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid
KG Warren and Ingrid Catz, University of Alberta
1992: Journal of the Neurological Sciences
Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue
KG Warren and Ingrid Catz, University of Alberta
1991: Journal of the Neurological Sciences
Optic neuritis anti-myelin basic protein synthetic peptide specificity
Kenneth G. Warren, Ingrid Catz and Kenneth Shutt
1989: Journal of the Neurological Sciences
Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. Detected during first exacerbations and kinetics of acute relapses and subsequent convalescent phases
KG Warren and Ingrid Catz, University of Alberta
July 1986: Annals of Neurology
A Correlation Between Cerebrospinal Fluid Myelin Basic Protein and Anti-Myelin Basic Protein in Multiple Sclerosis Patients
KG Warren and Ingrid Catz, University of Alberta
1986: Annals of Neurology
Diagnostic Value of Cerebrospinal Fluid Anti-Myelin Basic Protein in Patients with Multiple Sclerosis
KG Warren and Ingrid Catz, University of Alberta
1985: Annals of Neurology
The Relationship Between Levels of Cerebrospinal Fluid Myelin Basic Protein and IgG Measurements in Patients with Multiple Sclerosis
KG Warren and Ingrid Catz, University of Alberta
November 1983: Le Journal Canadien Des Sciences Neurologiques
Myelin Basic Protein: A Component of Circulating Immune Complexes in Multiple Sclerosis
Mrinal K. Dasgupta, Ingrid Catz, Kenneth G. Warren, Thomas A. McPherson, John B. Dossetor, Patrick R. Carnegie